Physician profile
Patrick Tiffany
NPI 1619504339
$734.17
in general payments reported to CMS, 2019-2025
15 companies · $374 in 2025
The $374 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $32.12 · 2024: $328 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $124.26 | 2025 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $83.00 | 2024-2025 | Qelbree |
| Corium, LLC | $81.42 | 2024-2025 | Azstarys |
| Vertical Pharmaceuticals, LLC | $74.06 | 2024-2025 | Relexxii |
| Ironshore Pharmaceuticals INC. | $61.38 | 2023-2024 | Jornay Pm |
| Cranial Technologies, INC | $59.70 | 2024-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $58.34 | 2024-2025 | |
| Amphastar Pharmaceuticals, INC. | $43.99 | 2024 | Baqsimi |
| Pfizer INC. | $38.36 | 2024 | |
| Tris Pharma INC | $20.52 | 2025 | Onyda Xr |
| Kaleo, INC. | $20.15 | 2024 | Auvi-Q |
| Lnhc, INC | $19.41 | 2025 | Zelsuvmi |
| Seqirus USA INC | $18.80 | 2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $15.51 | 2024 | Gardasil, Vaxneuvance, Gardasil 9 |
| Verrica Pharmaceuticals INC. | $15.27 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Tiffany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.